Conmed (CNMD) Receivables (2010 - 2026)

Conmed has reported Receivables for 17 years, with the latest figure at $228.7 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 3.4% year-over-year to $228.7 million; the trailing twelve-month figure through Mar 2026 stood at $228.7 million (up 3.4% YoY), and the FY2025 full-year result was $247.8 million, up 4.25% from the prior year.
• Receivables for Q1 2026 stood at $228.7 million, down from $247.8 million in the prior quarter.
• The five-year high for Receivables was $247.8 million in Q4 2025, with the low at $183.2 million in Q1 2022.
• Historically, Receivables has averaged $223.3 million across 5 years, with a median of $229.3 million in 2023.
• Annual changes were most pronounced in 2023 — Receivables increased 26.62% — and 2025, when it dropped 8.42%.
• Conmed's Receivables stood at $191.3 million in 2022, then grew by 26.62% to $242.3 million in 2023, then fell by 1.88% to $237.7 million in 2024, then rose by 4.25% to $247.8 million in 2025, then decreased by 7.73% to $228.7 million in 2026.
• The last three Receivables figures came in at $228.7 million (Q1 2026), $247.8 million (Q4 2025), and $224.9 million (Q3 2025), per Business Quant data.